|Cancer specialist expands GYN team
Oncology team expanded Aug. 1 to include ovarian cancer specialist and
minimally-invasive robotic surgeon Whitney Spannuth Graybill, M.D.
The Tennessee native came to MUSC from the University of Texas M.D.
Anderson Cancer Center in Houston where she completed her master’s
degree in cancer biology in 2008 and research fellowship in the
Department of Gynecologic Oncology.
“Dr. Graybill is a wonderful addition to our gynecologic oncology
specialty practice team,” said Jennifer L. Young, M.D., assistant
professor in the Department of Obstetrics and Gynecology. Last year,
Young had the distinction of being South Carolina’s first female
gynecologic oncologist. Graybill joins MUSC as the state’s second
female specialist and completes MUSC’s four-member gynecologic oncology
team, which includes Young, William T. Creasman, M.D., Distinguished
University Professor and Matthew F. Kohler, M.D., professor and
director of gynecologic oncology, Department of Obstetrics and
Graybill’s work on ovarian cancer and translational research has led to
a better understanding of tumors and the development of new drugs and
therapies now being offered to cancer patients at MUSC. Her skill
as a robotic surgeon allows her to conduct detailed gynecologic
procedures using robotics and small incisions that reduce pain and
anxiety, and shortens the recovery time for patients.
“I’m excited and honored to be here and look forward to providing the
best patient care, new drug therapies and techniques that will help
improve outcomes for women with cancer,” said Graybill.
Graybill earned her undergraduate degree in psychology from Vanderbilt
University in Nashville. She is a 2002 graduate from Quillen College of
Medicine in her hometown of Johnson City, Tenn. She went on to complete
her residency training at the University of Alabama School of
Medicine’s Department Obstetrics and Gynecology.
Graybill’s research and clinical work has appeared in more than 70
peer-reviewed journals and abstracts.
For information, visit Hollings Cancer Center’s Gynecologic Cancer
Friday, Sept. 10, 2010